Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Waitstill who wrote (573)	2/27/1998 4:00:00 PM
From: Rocketman	Read Replies (1) \| Respond to of 3202

Well, INCY hasn't announced any new customers in almost two months, and have only just recently signed up Pfizer their first customer to a new deal. The sky must be falling. It just isn't a good momentum stock this week I guess. Actually, if anyone has access to the full Furman Selz report, I'd love to see what they give as a reason. Hey Roy, Randy and Denise, get those sales people in gear!!! @;-> Rman

To: Waitstill who wrote (573)	2/28/1998 10:56:00 PM
From: George Sepetjian	Respond to of 3202

Maybe it's the P/E Incyte has a current p/e of approximately 100! Estimated earnings drop that down to the mid 50's. I think the selling is strictly some short term profit taking. Volume is flat. 4 weeks ago Incyte moved up 6 5/8 pts for the week. During the last 3 weeks it has dropped 4 1/2 pts. Sometimes analysts downgrade stocks simply because they have hit certain price targets. And in hindsight selling 3 weeks ago would have been a smart move. Long term-Irrelevant.